CBR-3465

• Description :

  CBR-3465 is a mycobacterium tuberculosis (Mtb) type II NADH dehydrogenase inhibitor, with the MIC of 0.16 μM against Mtb[1].

• UNSPSC :

  12352005

• Target :

  Bacterial

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/cbr-3465.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C1N=C(NC2=C1C(F)=CC=C2)SCC(NC3CCCCC3)=O

• Molecular Formula :

  C16H18FN3O2S

• Molecular Weight :

  335.40

• References & Citations :

  [1]Harbut MB, et, al. Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity. Angew Chem Int Ed Engl. 2018 Mar 19;57 (13) :3478-3482.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2225883-59-8]